Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-01 Sale | 2023-06-02 5:03 pm | Sensei Biotherapeutics Inc. | SNSE | Apeiron Investment Group Ltd. Angermayer Christian Presight Sensei Co-Invest Fund L.P. Presight Co-Invest Management L.L.C. 10% Owner | 3,441,661 | $1.58 | $5,437,824 | 0 (Indirect) | View |
| 2023-02-23 Purchase | 2023-02-27 8:10 pm | Sensei Biotherapeutics Inc. | SNSE | Apeiron Investment Group Ltd. Angermayer Christian Presight Sensei Co-Invest Fund L.P. Presight Co-Invest Management L.L.C. 10% Owner | 2,200 | $1.6086 | $3,539 | 3,441,661 (Indirect) | View |
| 2022-03-02 Purchase(A) | 2022-06-10 2:18 pm | Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner | 1,203 | $3.2 | $3,850 | 5,231,488 (Indirect) | View |
| 2022-03-02 Purchase(A) | 2022-06-10 2:17 pm | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 1,203 | $3.2 | $3,850 | 5,231,488 (Direct) | View |
| 2021-03-23 Purchase(A) | 2022-04-21 4:25 pm | Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner | 9,500 | $14.34 | $136,230 | 4,798,293 (Indirect) | View |
| 2021-02-18 Purchase(A) | 2022-04-21 4:22 pm | Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner | 752 | $19.75 | $14,852 | 4,690,905 (Indirect) | View |
| 2021-03-23 Purchase(A) | 2022-04-21 4:19 pm | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 9,500 | $14.34 | $136,230 | 4,798,293 (Direct) | View |
| 2021-02-18 Purchase(A) | 2022-04-21 4:17 pm | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 752 | $19.75 | $14,852 | 4,690,905 (Direct) | View |
| 2022-03-02 Purchase | 2022-03-02 1:42 pm | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 1,203 | $3.2 | $3,850 | 5,231,989 (Direct) | View |
| 2022-03-02 Purchase | 2022-03-02 1:40 pm | Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner | 1,203 | $3.2 | $3,850 | 5,231,989 (Indirect) | View |
| 2022-02-28 Purchase | 2022-03-01 6:55 pm | Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner | 2,500 | $3.6 | $9,000 | 5,230,786 (Indirect) | View |
| 2022-02-28 Purchase | 2022-03-01 6:53 pm | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 2,500 | $3.6 | $9,000 | 5,230,786 (Direct) | View |
| 2022-02-25 Purchase | 2022-02-28 4:53 pm | Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner | 2,500 | $3.65 | $9,125 | 5,228,286 (Indirect) | View |
| 2022-02-25 Purchase | 2022-02-28 4:50 pm | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 2,500 | $3.65 | $9,125 | 5,228,286 (Direct) | View |
| 2022-02-23 Purchase | 2022-02-24 7:15 pm | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 17,500 | $3.6543 | $63,950 | 5,225,786 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-15 Option Award(A) | 2023-03-29 5:17 pm | N/A 2033-02-14 | Sensei Biotherapeutics Inc. | SNSE | Colgan Erin Chief Financial Officer | 141,346 | $0 | 169,032 (Direct) | View |
| 2023-02-15 Option Award(A) | 2023-03-29 5:16 pm | N/A 2033-02-14 | Sensei Biotherapeutics Inc. | SNSE | Celebi John President and CEO | 163,193 | $0 | 221,303 (Direct) | View |
| 2023-02-15 Option Award(A) | 2023-03-29 5:13 pm | N/A 2023-02-14 | Sensei Biotherapeutics Inc. | SNSE | Gallagher Patrick Stephen Chief Business Officer | 103,513 | $0 | 103,513 (Direct) | View |
| 2022-06-10 Option Award(A) | 2023-03-07 5:15 pm | N/A 2032-06-09 | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 19,016 | $0 | 5,250,506 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 5:01 pm | N/A 2033-02-14 | Sensei Biotherapeutics Inc. | SNSE | van der Horst Edward Chief Scientific Officer | 116,265 | $0 | 137,438 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 5:01 pm | N/A 2023-02-14 | Sensei Biotherapeutics Inc. | SNSE | Gallagher Patrick Stephen Chief Business Officer | 103,513 | $0 | 103,515 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 5:01 pm | N/A 2033-02-14 | Sensei Biotherapeutics Inc. | SNSE | Colgan Erin Chief Financial Officer | 141,346 | $0 | 163,032 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 5:00 pm | N/A 2033-02-14 | Sensei Biotherapeutics Inc. | SNSE | Celebi John President and CEO | 163,193 | $0 | 217,307 (Direct) | View |
Ownership | 2022-12-16 4:30 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | van der Horst Edward Chief Scientific Officer | 0 | $0 | 216,422 (Direct) | View |
| 2022-06-10 Option Award(A) | 2022-08-01 5:45 pm | N/A 2032-06-09 | Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner | 19,016 | $0 | 5,250,506 (Indirect) | View |
Ownership(A) | 2022-08-01 5:40 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner | 0 | $0 | 117,854,170 (Indirect) | View |
Ownership | 2022-07-20 09:53 am | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Apeiron Investment Group Ltd. Angermayer Christian Presight Co-Invest Management L.L.C. 10% Owner | 0 | $0 | 3,439,461 (Indirect) | View |
| 2022-06-10 Option Award | 2022-06-14 4:55 pm | N/A 2032-06-09 | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 19,016 | $0 | 5,250,504 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:54 pm | N/A 2032-06-09 | Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner | 19,016 | $0 | 5,250,504 (Indirect) | View |
| 2022-06-10 Option Award | 2022-06-14 4:15 pm | N/A 2032-06-09 | Sensei Biotherapeutics Inc. | SNSE | Vojta Deneen Director | 19,016 | $0 | 19,016 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:15 pm | N/A 2032-06-09 | Sensei Biotherapeutics Inc. | SNSE | English Jessie Director | 19,016 | $0 | 19,016 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:15 pm | N/A 2032-06-09 | Sensei Biotherapeutics Inc. | SNSE | RICKS THOMAS G Director | 19,016 | $0 | 353,947 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:15 pm | N/A 2032-06-09 | Sensei Biotherapeutics Inc. | SNSE | Humer Kristian Director | 19,016 | $0 | 19,016 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:15 pm | N/A 2032-06-09 | Sensei Biotherapeutics Inc. | SNSE | Broder Samuel Director | 19,016 | $0 | 19,016 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:15 pm | N/A 2032-06-09 | Sensei Biotherapeutics Inc. | SNSE | Holmen Bob Director | 19,016 | $0 | 35,682 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:20 pm | N/A 2032-05-31 | Sensei Biotherapeutics Inc. | SNSE | Gallagher Patrick Stephen Chief Business Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-03-08 Option Award | 2022-03-09 6:24 pm | N/A 2032-03-07 | Sensei Biotherapeutics Inc. | SNSE | RINGO WILLIAM R Director | 48,033 | $0 | 48,033 (Direct) | View |